Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Takahiro , Akita"'
Autor:
Takahiro Akita, Ryo Ariyasu, Sho Kakuto, Keiki Miyadera, Ayu Kiritani, Ryosuke Tsugitomi, Yoshiaki Amino, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Sadatomo Tasaka, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 15, Iss 10, Pp 788-796 (2024)
Abstract Background It is difficult to predict gene mutations individually based on clinical background alone. Tumor markers may help to predict each gene mutation. Identifying tumor markers that can predict gene mutation will facilitate timely genet
Externí odkaz:
https://doaj.org/article/93acc07c0f8341ceb4a0c0b39dc0fe16
Autor:
Ayu Kiritani, Yoshiaki Amino, Ken Uchibori, Takahiro Akita, Yuhei Harutani, Shinsuke Ogusu, Ryosuke Tsugitomi, Ryo Manabe, Ryo Ariyasu, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 15, Iss 5, Pp 402-409 (2024)
Abstract Background As an epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI), osimertinib has emerged as a standard EGFR‐mutation positive treatment for non‐small cell lung cancer (NSCLC). However, the efficacy of osimertin
Externí odkaz:
https://doaj.org/article/bf9f4e65fe294138b6c32c0d9d62d1af
Autor:
Yoshiaki Amino, Siew‐Kee Low, Hironori Ninomiya, Ayu Kiritani, Keiki Miyadera, Sho Kakuto, Takahiro Akita, Ryosuke Tsugitomi, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 14, Iss 33, Pp 3317-3322 (2023)
Abstract Background KRAS mutation positive lung cancer is known to be clinically characterized by older age, males, and smokers. It is reported to be more common in mucinous adenocarcinoma, but all reports are based on analysis of tissue samples. Rec
Externí odkaz:
https://doaj.org/article/65050a39348140f4a87a937f35d99782
Autor:
Ryo Ariyasu, MD, Sho Kakuto, MD, Keiki Miyadera, MD, Takahiro Akita, MD, Ayu Kiritani, MD, Ryosuke Tsugitomi, MD, Yoshiaki Amino, MD, Ken Uchibori, MD, PhD, Satoru Kitazono, MD, PhD, Noriko Yanagitani, MD, PhD, Makoto Nishio, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 6, Pp 100524- (2023)
Introduction: Only a few reports have determined whether recently advanced anticancer drugs, particularly next-generation tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs), prolong the survival of patients with NSCLC in the re
Externí odkaz:
https://doaj.org/article/461d74d1b3d4494e8199e62cc0a7c7d3
Autor:
Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, Fumiyoshi Ohyanagi, Yosuke Kawashima, Yuichi Tambo, Azusa Tanimoto, Atsushi Horiike, Eisaku Miyauchi, Yuko Tsuchiya‐Kawano, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 13, Iss 10, Pp 1471-1478 (2022)
Abstract Background Dacomitinib is the second‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitor (TKI) for mutant non–small cell lung cancer (NSCLC). EGFR‐TKIs are often re‐administered in Japan after the disease p
Externí odkaz:
https://doaj.org/article/5e5f715847fd4a66aa35dd6d0e976bda
Publikováno v:
Economics & Management Series = Economics & Management Series.
The COVID-19 pandemic has exerted an enormous impact on the Indonesian economy. In 2020, the country contracted by 2.7%. But, the impact has been spatially heterogeneous. Based on provincial GDP by industrial sectors, this study examines how structur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::199b5d381a6506f273d8daee0b7208df
http://id.nii.ac.jp/1509/00000961/
http://id.nii.ac.jp/1509/00000961/
Autor:
Siew-Kee, Low, Ryo, Ariyasu, Ken, Uchibori, Rie, Hayashi, Hiu Ting, Chan, Yoon Ming, Chin, Takahiro, Akita, Yuhei, Harutani, Ayu, Kiritani, Ryosuke, Tsugitomi, Ryo, Manabe, Shinsuke, Ogusu, Yoshiaki, Amino, Satoru, Kitazono, Noriko, Yanagitani, Yusuke, Nakamura, Makoto, Nishio
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The turnaround time is one of important issues to deliver results timely for clinical decisions. The Ion Torrent™ Genexus™ Integrated Sequencer aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6714c5cce1454eef30da0abcb17473de
https://doi.org/10.21037/tlcr-21-981
https://doi.org/10.21037/tlcr-21-981
Autor:
Takahiro Akita, Dorji Lethro
Publikováno v:
Journal of the Asia Pacific Economy. :1-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61b001e524a69934bf2e28505323d25b
https://doi.org/10.1080/13547860.2022.2054132
https://doi.org/10.1080/13547860.2022.2054132
Autor:
Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, Fumiyoshi Ohyanagi, Yosuke Kawashima, Yuichi Tambo, Azusa Tanimoto, Atsushi Horiike, Eisaku Miyauchi, Yuko Tsuchiya‐Kawano, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer. 13:1471-1478
Dacomitinib is the second-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) for mutant non-small cell lung cancer (NSCLC). EGFR-TKIs are often re-administered in Japan after the disease progression prior EGFR-TKI. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e50b03e834fc679d2af36700d8c9e3c
https://doi.org/10.1111/1759-7714.14415
https://doi.org/10.1111/1759-7714.14415
Autor:
Liang Tan, Takahiro Akita
Publikováno v:
Sustainability; Volume 15; Issue 1; Pages: 401
The paper explores the changes in the determinants of interprovincial inequality in China during the period of 2000 to 2017 by way of bi-dimensional decomposition method. The method integrates two inequality decompositions by both regional groups and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1267fd0ee0675c6cb113e2ae46c16c7